Terms: = Kidney tumors AND RARA, RAR, 5914, ENSG00000131759, NR1B1
38 results:
1. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
Mae SI; Hattanda F; Morita H; Nozaki A; Katagiri N; Ogawa H; Teranaka K; Nishimura Y; Kudoh A; Yamanaka S; Matsuse K; Ryosaka M; Watanabe A; Soga T; Nishio S; Osafune K
Cell Rep; 2023 Dec; 42(12):113431. PubMed ID: 38039961
[TBL] [Abstract] [Full Text] [Related]
2. Synthetic Retinoids Beyond Cancer Therapy.
Gudas LJ
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():155-175. PubMed ID: 34516292
[TBL] [Abstract] [Full Text] [Related]
3. Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma.
Peng Z; Hu Y; Ren J; Yu N; Li Z; Xu Z
Int J Med Sci; 2021; 18(1):99-108. PubMed ID: 33390778
[TBL] [Abstract] [Full Text] [Related]
4. Clear-cell carcinoma with sarcomatoid pattern, associated with gingival metastasis. Case report and review of the literature.
Cortés-Vázquez YD; Cortés-Vázquez AR; Priego-Niño A; Fernández-Vivar E; Silva-Bravo F; Gutiérrez-Quiróz C
Cir Cir; 2020; 88(Suppl 1):54-58. PubMed ID: 32963404
[TBL] [Abstract] [Full Text] [Related]
5. Late metastasis of right breast cancer to renal pelvis and right ureter. A case report.
Mejía-Ríos LC; Ramírez-Vega R; Reyes-Arroyo J; Salgado-Arroyo V; Castillo-Canto CO; Montiel-Jarquín ÁJ
Cir Cir; 2020; 88(Suppl 1):83-86. PubMed ID: 32963383
[TBL] [Abstract] [Full Text] [Related]
6. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death.
Yago-Ibáñez J; García-Pastor C; Lucio-Cazaña FJ; Fernández-Martínez AB
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165795. PubMed ID: 32278009
[TBL] [Abstract] [Full Text] [Related]
7. Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.
Percicote AP; Mardegan GL; Gugelmim ES; Ioshii SO; Kuczynski AP; Nagashima S; de Noronha L
Diagn Pathol; 2018 Jan; 13(1):9. PubMed ID: 29378601
[TBL] [Abstract] [Full Text] [Related]
8. Radiolabeling and initial biological evaluation of [
Solingapuram Sai KK; Das BC; Sattiraju A; Almaguel FG; Craft S; Mintz A
Bioorg Med Chem Lett; 2017 Mar; 27(6):1425-1427. PubMed ID: 28216044
[TBL] [Abstract] [Full Text] [Related]
9. Hormone signaling pathways as treatment targets in renal cell cancer (Review).
Czarnecka AM; Niedzwiedzka M; Porta C; Szczylik C
Int J Oncol; 2016 Jun; 48(6):2221-35. PubMed ID: 27035677
[TBL] [Abstract] [Full Text] [Related]
10. Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma.
Li L; Yang C; Zhao Z; Xu B; Zheng M; Zhang C; Min Z; Guo J; Rong R
Mol Med Rep; 2015 Feb; 11(2):947-53. PubMed ID: 25352158
[TBL] [Abstract] [Full Text] [Related]
11. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Desphande A; Xia G; Boerma LJ; Vines KK; Atigadda VR; Lobo-Ruppert S; Grubbs CJ; Moeinpour FL; Smith CD; Christov K; Brouillette WJ; Muccio DD
Bioorg Med Chem; 2014 Jan; 22(1):178-85. PubMed ID: 24359708
[TBL] [Abstract] [Full Text] [Related]
12. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.
Hauser S; Zahalka T; Fechner G; Müller SC; Ellinger J
Anticancer Res; 2013 Oct; 33(10):4651-6. PubMed ID: 24123044
[TBL] [Abstract] [Full Text] [Related]
13. The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors.
Lenko V; Bialesova L; Macejova D; Bujdak P; Breza J; Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):316-24. PubMed ID: 24077234
[TBL] [Abstract] [Full Text] [Related]
14. All-trans retinoic acid is capable of inducing folate receptor β expression in KG-1 cells.
Xu Y; Wang T; Tang R; Tang S
Tumour Biol; 2010 Dec; 31(6):589-95. PubMed ID: 20632143
[TBL] [Abstract] [Full Text] [Related]
15. Regulation of the hyaluronan synthase 2 gene by convergence in cyclic AMP response element-binding protein and retinoid acid receptor signaling.
Makkonen KM; Pasonen-Seppänen S; Törrönen K; Tammi MI; Carlberg C
J Biol Chem; 2009 Jul; 284(27):18270-81. PubMed ID: 19416972
[TBL] [Abstract] [Full Text] [Related]
16. [Methylation of promoter region of rar-beta2 gene in renal cell, breast, and ovarian carcinomas].
Khodyrev DS; Loginov VI; Pronina IV; Kazubskaia TP; Gar'kavtseva RF; Braga EA
Genetika; 2008 Aug; 44(8):1126-32. PubMed ID: 18825962
[TBL] [Abstract] [Full Text] [Related]
17. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract] [Full Text] [Related]
18. rar-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention?
Goelden U; Ukena SN; Pfoertner S; Hofmann R; Buer J; Schrader AJ
Exp Oncol; 2005 Sep; 27(3):220-4. PubMed ID: 16244585
[TBL] [Abstract] [Full Text] [Related]
19. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
[TBL] [Abstract] [Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract] [Full Text] [Related]
[Next]
